Respiratory tract diseases are common human ailments with which people, especially children, are brought to health facilities. Upper respiratory tract infection (URTI) mainly includes rhinitis, nasopharyngitis, acute sinusitis, tonsillitis, otitis media, acute mastoiditis, laryngotracheobronchitis (croup), acute epiglottitis and diphtheria. In developing countries, on an average, every child has 6.8 to 8.8 episodes of URTI per year, accounting for 30 to 50% of the total paediatric outpatient visits and 20-30% of the paediatric admissions. Though homoeopathic medicines showed its positive result in URTI, but rigorous clinical trials has scarcity. In this double-blind, randomized, placebo-controlled trial at D. N. De Homoeopathic Medical College and Hospital, 60 children suffering from URTI will be randomized to either individualized homoeopathic medicines (verum; n=30) or identical-looking placebo (control; n=30). We aim to investigate whether there are any differences in outcomes between these two groups over 3 months of intervention. Wisconsin Upper Respiratory Symptom Survey (WURSS-21) scores, Canadian Acute Respiratory Illness and Flu Scale (CARIFS) questionnaire scores and URI symptom severity scale (URI-SSS) scores will be used as the primary and econdary outcome measures respectively. Comparative analysis will be carried out to examine group differences, if any. Results will be published in scientific journals.